Evaluation of fluticasone propionate (500 μg day−1) administered either as dry powder via a Diskhaler® inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 μg day−1) administered by pressurized inhaler
- 30 November 1993
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 87 (8) , 609-620
- https://doi.org/10.1016/s0954-6111(05)80264-1
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Inhaled corticosteroids: benefits and risks.Thorax, 1992
- Asthma: a follow up statement from an international paediatric asthma consensus group.Archives of Disease in Childhood, 1992
- Structure-activity relationships of topically active steroids: the selection of fluticasone propionateRespiratory Medicine, 1990
- The human pharmacology of fluticasone propionateRespiratory Medicine, 1990
- Guidelines for management of asthma in adults: I--Chronic persistent asthma. Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign.BMJ, 1990
- Patient error in use of bronchidilator metered aerosols.BMJ, 1976
- Misuse of Inhaled Bronchodilator AgentsBMJ, 1965